Kevin Horvath
Adolescent Medicine · Tipp City, OHNPI 1033219365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 604 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Among adolescent medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 604 payments — averaging $11.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$1K
- Supernus Pharmaceuticals, Inc.$1K
- Ironshore Pharmaceuticals Inc.$858
- Tris Pharma Inc$635
- Takeda Pharmaceuticals U.S.A., Inc.$546
- Neos Therapeutics, LP$440
- plus $2K from 10 others
What the payments were for
- Food & beverage$6,891100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 150 | $1,430 |
| Supernus Pharmaceuticals, Inc. | 101 | $1,184 |
| Ironshore Pharmaceuticals Inc. | 86 | $858 |
| Tris Pharma Inc | 68 | $635 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $546 |
| Neos Therapeutics, LP | 37 | $440 |
| Noven Therapeutics, LLC | 25 | $438 |
| Otsuka America Pharmaceutical, Inc. | 26 | $405 |
| Collegium Pharmaceutical, Inc. | 26 | $333 |
| Vertical Pharmaceuticals, LLC | 24 | $305 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $160 |
| Rhodes Pharmaceuticals L.p. | 4 | $68 |
| Adlon Therapeutics L.p. | 3 | $42 |
| AbbVie | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
How this compares
$6,904 in reported general payments places this provider in the 90th percentile of 58 adolescent medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 18 | $2,555 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $965 |
| Benztropine Mesylate | 19 | $392 |
| Hydroxyzine Pamoate | 33 | $275 |
| Clonidine Hcl | 19 | $78 |
| Sertraline Hcl | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other adolescent medicine in Tipp City
- Alan WilimitisTipp City$1K
- Kathryn DearingTipp City$594
- Elise BerlanColumbus$36K
- Nicole BaldwinCincinnati$24K
- David RoerDayton$19K
- Jessica KahnCincinnati$11K
- Darcey ThorntonCincinnati$6K
- Veronica IssacCleveland$3K
- Tracy WickDayton$3K
- Stephen SondikeAkron$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.